VTOL · Bristow Group Inc. · Insider Trading

The shares to which this Form 4 relates are held directly or indirectly by certain funds and accounts (collectively, "Clients") managed by Solus Alternative Asset Management LP ("Solus") and/or affiliates thereof. Solus GP LLC ("Solus GP") is the general partner of Solus. Christopher Pucillo is the managing member of Solus GP (collectively, the "Reporting Persons"). Each may be deemed to have beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The Solus Clients expressly disclaim beneficial ownership of any shares of Common Stock. Pursuant to Rule 16a-1(a)(1), the Reporting Persons are not deemed to beneficially own the securities but have elected to file this Form 4 nevertheless.

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934, as amended.

The shares to which this Form 4 relates are held directly or indirectly by certain funds and accounts (collectively, "Clients") managed by Solus Alternative Asset Management LP ("Solus") and/or affiliates thereof. Solus GP LLC ("Solus GP") is the general partner of Solus. Christopher Pucillo is the managing member of Solus GP (collectively, the "Reporting Persons"). Each may be deemed to have beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The Solus Clients expressly disclaim beneficial ownership of any shares of Common Stock. Pursuant to Rule 16a-1(a)(1), the Reporting Persons are not deemed to beneficially own the securities but have elected to file this Form 4 nevertheless.

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on September 22, 2026 at prices ranging from $41.96 to $42.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.0000 to $43.0500 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

The shares to which this Form 4 relates are held directly or indirectly by certain funds and accounts (collectively, "Clients") managed by Solus Alternative Asset Management LP ("Solus") and/or affiliates thereof. Solus GP LLC ("Solus GP") is the general partner of Solus. Christopher Pucillo is the managing member of Solus GP (collectively, the "Reporting Persons"). Each may be deemed to have beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The Solus Clients expressly disclaim beneficial ownership of any shares of Common Stock. Pursuant to Rule 16a-1(a)(1), the Reporting Persons are not deemed to beneficially own the securities but have elected to file this Form 4 nevertheless.

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934, as amended.

The shares to which this Form 4 relates are held directly or indirectly by certain funds and accounts (collectively, "Clients") managed by Solus Alternative Asset Management LP ("Solus") and/or affiliates thereof. Solus GP LLC ("Solus GP") is the general partner of Solus. Christopher Pucillo is the managing member of Solus GP (collectively, the "Reporting Persons"). Each may be deemed to have beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The Solus Clients expressly disclaim beneficial ownership of any shares of Common Stock. Pursuant to Rule 16a-1(a)(1), the Reporting Persons are not deemed to beneficially own the securities but have elected to file this Form 4 nevertheless.

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934, as amended.

The shares to which this Form 4 relates are held directly or indirectly by certain funds and accounts (collectively, "Clients") managed by Solus Alternative Asset Management LP ("Solus") and/or affiliates thereof. Solus GP LLC ("Solus GP") is the general partner of Solus. Christopher Pucillo is the managing member of Solus GP. Each may be deemed to have beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The Solus Clients expressly disclaim beneficial ownership of any shares of Common Stock. Pursuant to Rule 16a-1(a)(1), the Reporting Persons are not deemed to beneficially own the securities but have elected to file this Form 4 nevertheless.

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.6000 to $45.85000 inclusive. The Reporting Person undertakes to provide to the Issuer, any security hold of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

The shares to which this Form 4 relates are held directly or indirectly by certain funds and accounts (collectively, "Clients") managed by Solus Alternative Asset Management LP ("Solus") and/or affiliates thereof. Solus GP LLC ("Solus GP") is the general partner of Solus. Christopher Pucillo is the managing member of Solus GP. Each may be deemed to have beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The Solus Clients expressly disclaim beneficial ownership of any shares of Common Stock. Pursuant to Rule 16a-1(a)(1), the Reporting Persons are not deemed to beneficially own the securities but have elected to file this Form 4 nevertheless.

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on September 1, 2026 at prices ranging from $45.87 to $45.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.7500 to $46.0000 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

The shares to which this Form 4 relates are held directly or indirectly by certain funds and accounts (collectively, "Clients") managed by Solus Alternative Asset Management LP ("Solus") and/or affiliates thereof. Solus GP LLC ("Solus GP") is the general partner of Solus. Christopher Pucillo is the managing member of Solus GP. Each may be deemed to have beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein. The Solus Clients expressly disclaim beneficial ownership of any shares of Common Stock. Pursuant to Rule 16a-1(a)(1), the Reporting Persons are not deemed to beneficially own the securities but have elected to file this Form 4 nevertheless.

The Reporting Persons are jointly filing this Form 4 pursuant to Rule 16a-3(j) under the Securities Exchange Act of 1934, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on September 1, 2026 at prices ranging from $46.00 to $46.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 25, 2026 at prices ranging from $46.50 to $46.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 20, 2026 at prices ranging from $45.91 to $46.39, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 19, 2026 at prices ranging from $46.02 to $46.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 19, 2026 at prices ranging from $46.50 to $47.00, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on August 17, 2026 at prices ranging from $46.6525 to $46.78, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

Pursuant to the Bristow Group Inc. 2021 Equity Incentive Plan, as amended, the reporting person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Bristow Group Inc. The RSUs vest in full on June 3, 2027, subject to the reporting person's continued status as a director of Bristow Group Inc. as of the vesting date.

Pursuant to the Bristow Group Inc. 2021 Equity Incentive Plan, as amended, the reporting person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Bristow Group Inc. The RSUs vest in full on June 3, 2027, subject to the reporting person's continued status as a director of Bristow Group Inc. as of the vesting date.

Pursuant to the Bristow Group Inc. 2021 Equity Incentive Plan, as amended, the reporting person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Bristow Group Inc. The RSUs vest in full on June 3, 2027, subject to the reporting person's continued status as a director of Bristow Group Inc. as of the vesting date.

Pursuant to the Bristow Group Inc. 2021 Equity Incentive Plan, as amended, the reporting person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Bristow Group Inc. The RSUs vest in full on June 3, 2027, subject to the reporting person's continued status as a director of Bristow Group Inc. as of the vesting date.

Pursuant to the Bristow Group Inc. 2021 Equity Incentive Plan, as amended, the reporting person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Bristow Group Inc. The RSUs vest in full on June 3, 2027, subject to the reporting person's continued status as a director of Bristow Group Inc. as of the vesting date.

Pursuant to the Bristow Group Inc. 2021 Equity Incentive Plan, as amended, the reporting person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Bristow Group Inc. The RSUs vest in full on June 3, 2027, subject to the reporting person's continued status as a director of Bristow Group Inc. as of the vesting date.

Pursuant to the Bristow Group Inc. 2021 Equity Incentive Plan, as amended, the reporting person was granted restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of common stock of Bristow Group Inc. The RSUs vest in full on June 3, 2027, subject to the reporting person's continued status as a director of Bristow Group Inc. as of the vesting date.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions on March 24, 2026 at prices ranging from $45.1300 to $45.8450, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.

Shares withheld to cover the associated tax liability upon the vesting of the third portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 14, 2023.

Shares withheld to cover the associated tax liability upon the vesting of the third portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 14, 2023.

Shares withheld to cover the associated tax liability upon the vesting of the Cash Return on Invested Capital performance-based stock units ("Cash ROIC PSUs") granted to the reporting person on March 10, 2023 under the terms of the Issuer's 2021 Equity Incentive Plan (the "Plan").

Shares withheld to cover the associated tax liability upon the vesting of the Relative Total Stockholder Return performance-based stock units ("RTSR PSUs") granted to the reporting person on March 10, 2023 under the terms of the Plan.

Shares withheld to cover the associated tax liability upon the vesting of the third portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 14, 2023.

Shares withheld to cover the associated tax liability upon the vesting of the third portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 14, 2023.

Shares withheld to cover the associated tax liability upon the vesting of the Cash Return on Invested Capital performance-based stock units ("Cash ROIC PSUs") granted to the reporting person on March 10, 2023 under the terms of the Issuer's 2021 Equity Incentive Plan (the "Plan").

Shares withheld to cover the associated tax liability upon the vesting of the Relative Total Stockholder Return performance-based stock units ("RTSR PSUs") granted to the reporting person on March 10, 2023 under the terms of the Plan.

Shares withheld to cover the associated tax liability upon the vesting of the Cash Return on Invested Capital performance-based stock units ("Cash ROIC PSUs") granted to the reporting person on March 10, 2023 under the terms of the Issuer's 2021 Equity Incentive Plan (the "Plan").

Shares withheld to cover the associated tax liability upon the vesting of the Relative Total Stockholder Return performance-based stock units ("RTSR PSUs") granted to the reporting person on March 10, 2023 under the terms of the Plan.

Shares withheld to cover the associated tax liability upon the vesting of the Relative Total Stockholder Return performance-based stock units ("RTSR PSUs") granted to the reporting person on March 10, 2023 under the terms of the Plan.

Shares withheld to cover the associated tax liability upon the vesting of the Cash Return on Invested Capital performance-based stock units ("Cash ROIC PSUs") granted to the reporting person on March 10, 2023 under the terms of the Issuer's 2021 Equity Incentive Plan (the "Plan").

Shares withheld to cover the associated tax liability upon the vesting of the second portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 12, 2024.

Shares withheld to cover the associated tax liability upon the vesting of the second portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 12, 2024.

Shares withheld to cover the associated tax liability upon the vesting of the second portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 28, 2024.

Shares withheld to cover the associated tax liability upon the vesting of the second portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 12, 2024.

Shares withheld to cover the associated tax liability upon the vesting of the second portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 12, 2024.

Shares withheld to cover the associated tax liability upon the vesting of the first portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 5, 2025.

Shares withheld to cover the associated tax liability upon the vesting of the first portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 5, 2025.

Shares withheld to cover the associated tax liability upon the vesting of the first portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 5, 2025.

Represents a bona fide gift of the Issuer's common stock by the Reporting Person to charity.

Shares withheld to cover the associated tax liability upon the vesting of the first portion of a previous grant of restricted stock units, which grant was originally reported in Table I of the reporting person's Form 4 filed on March 5, 2025.